Clinical trial
Effect of the Anti-oxidant N-acetylcysteine on Beta-cell Function in Type 2 Diabetes
NCT01394510
Study timeline
Study start (unknown)2011-06-01Date precision: month
Registry last updated2016-06-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Oxidative Stressunresolved
Interventions
N-acetylcysteineDRUG
Sponsors & collaborators
Utzschneider, Kristina, M.D.lead sponsor
VA Puget Sound Health Care Systemcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01394510 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.